Drawing for ZYPEPTRI

USPTO serial 99026510

ZYPEPTRI

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
SUAREZ, MARIA VICTORIA
Law office
TMO LAW OFFICE 133

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ZYPEPTRI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

CHERYL L. FOYTLIN

CHERYL L. FOYTLIN Johnson & JohnsonONE JOHNSON & JOHNSON PLAZANEW BRUNSWICK, NJ 08933United States

Goods and services

ClassDescriptionStatusFirst use
005Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, alloimmune diseases, cardiovascular and pulmonary diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, hematological diseases, urological diseases, maternal fetal disordersACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (ABN6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Oct 13, 2026ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 13, 2026MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Feb 21, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Feb 20, 2026EX1GSOU EXTENSION 1 GRANTED—
Feb 20, 2026EXT1SOU EXTENSION 1 FILED—
Feb 20, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 9, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jul 31, 2025TMBNTTAB RELEASE CASE TO TRADEMARKS—
Jul 31, 2025OP.TOPPOSITION TERMINATED NO. 999999—
Jul 31, 2025OP.DOPPOSITION DISMISSED NO. 999999—
Jun 17, 2025DOCKASSIGNED TO EXAMINER—
Jun 9, 2025ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Jun 9, 2025OP.IOPPOSITION INSTITUTED NO. 999999—
May 7, 2025ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Apr 8, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 8, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 2, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 13, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 13, 2025DOCKASSIGNED TO EXAMINER—
Feb 3, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 3, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 3, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance